The Dawn of a New Era in Health is Here

Kihealth is a life sciences company focused on research, development and commercialization of novel diagnostics, products and services for the treatment of metabolic disease and related indications.

The diabetes diagnostics today look only at blood sugar leaving 1/3 of the people undiagnosed.

There is a high rate of false positives with current diagnostic options and inaccurate results based on diet and hemoglobin traits.

People deserve a more accurate and early predictor for diabetes

1/3 people are undiagnosed

25% of children diagnosed with type 1 diabetes are misdiagnosed initially, leading to 18% getting DKA. We can reduce the death rate in children through early detection.

25% of children are misdiagnosed

Diabetes It is the 7th leading cause of death in the United States. Early detection and acute intervention can delay or mitigate onset of disease and reduce the death rate.

1.1 million people died of diabetes last year

People deserve to live their lives to the fullest.

Photo of a happy family
A photo of a old women who is super healthy and doing exercise

The key
to longevity

By focusing on the root cause of disease we have the opportunity to prevent the onset of disease. We are paving the way for prevention with new science and unlocking the answers to how to prevent people from developing metabolic diseases that do not have a cure.

We aim to bring this approach to disrupt the status quo and give people the keys to longevity and high-quality of life.

Transforming the approach

We are seeking to arm people with the knowledge of their risk of developing diabetes long before they experience symptoms and when they have an opportunity to intervene and prevent or delay onset of disease.

We are bringing novel, first in class diagnostics to the market through revolutionary approaches and partnerships with leading education institutions like Yale University.

We are bringing forward a new era in how disease is tracked and prevented.

A female scientiest looking at a microscope

The first diagnostic that will offer the earliest detection for diabetes.

Our diabetes diagnostic test

Our test will become the leading diagnostic tool to track and inform people of the onset or potential onset of Diabetes. Arming consumers with the knowledge they need to prevent and prepare from the comfort of home.

Our test uses a proprietary measure to identify and detect potential onset of type 1 and the development of pre-diabetes and type 2 diabetes. Our test will revolutionize the identification and potential treatment options for the most expensive disease in the world.

The test is designed to compliment the current method of identifying diabetes, the A1c Test, and can be used to manage diabetes through identifying the severity of β-cell death.

Although the A1c Test is currently recognized as the gold standard test in Diabetes management, our data supports that our test identifies Diabetes in people earlier than the A1c Test.

Early detection of Diabetes provides various benefits including, but not limited to, the potential for earlier treatments and lessened severity of the disease as a result.

Yale university logo
University logo

Created, validated and patented at Yale University by Dr. Kevan Herold, MD

Empowering a brighter future

At Kihealth, our vision is to give people key insights about their health to empower them to create and live their lives to the fullest.

We strive to put science and people at the forefront of everything we do. We see every day as an opportunity to move forward to creating a brighter future for everyone at risk of developing diabetes. We use our values as the foundation of the work we create and foster.

We are a group of individuals committed to turning the tide on disease and giving people the knowledge, tools and understanding they deserve so they can dictate their own health and happiness. We want to create a world where people know how the human body works and they have the power to control their destiny.

Our team

Leadership Team

Jennifer Anderson

Robert Mons

Mary Beth Sykes

Matthew Benson, MD

Diane Scaduto, PhD, HCLD (ABB)

Clifford Morris, PhD, ABAAHP

Board of Directors

Scott Blum

Parker Kelly, CPA


Camillo Ricordi, MD

Larry A. Fox, MD

Jin Xiong-She, Ph.D.

Jonathan Lakey, Ph.D.

Eitan Akirav, Ph.D.

Shadi Abdelnour, MD, FACE

The Future of Better Health has Arrived

Join our waitlist and be part of the dawn of a new era in Health.

Thank you for joining our email list. We will keep you abreast of updates.
Oops! Something went wrong while submitting the form.